Clinician's Roundtable

Host: Lee Freedman, MD

Guest: Carol A. Burke, MD, FACG, FASGE, AGAF, FACP

Dr. Carol Burke, Director of the Center for Colon Polyp & Cancer Prevention at the Cleveland Clinic, discusses follow-up after colonoscopies, for patients of varying degrees of risk, with your host, Dr. Lee Freedman.

Host: Lee Freedman, MD

Guest: Carol A. Burke, MD, FACG, FASGE, AGAF, FACP

A colon cancer screening is virtually implicit with colonoscopies. But, when should follow-up exams be performed in patients with varying degrees of risk? Dr. Carol Burke, Director of the Center for Colon Polyp & Cancer Prevention at the Cleveland Clinic, discusses colon cancer screening modalities with your host, Dr. Lee Freedman.

Host: Bill Rutenberg, MD

Guest: Lise Alschuler, ND

Dr. Lise Alschuler, Director of the Naturopathic Medicine Department at Cancer Treatment Centers of America, talks with host Dr. Bill Rutenberg about the CTCA's comprehensive Care model to treat cancer patients.

Host: Bill Rutenberg, MD

Guest: Lise Alschuler, ND

Most patients want access to every tool available to them while battling cancer and often look to their physicians for help. In addition to chemotherapy and radiation, there are many non-conventional treatment options to consider, many of which complement the impact of radiation and chemotherpy. Join host Dr. Bill Rutenberg talk with Lise Alschuler, ND, Director of the Naturopathic Medicine Department at Cancer Treatment Centers of America, to learn more about non-tradtional cancer treatments and the benefit of collaborative approaches to treating cancer patients.

Host: Bill Rutenberg, MD

Guest: Lise Alschuler, ND

Join host Dr. Bill Rutenberg speaking with Dr. Lise Alschuler, ND about the book she recently co-authored, titled Definitive Guide to Cancer: An Integrated Approach to Prevention, Treatment and Healing.

Host: Maurice Pickard, MD

Guest: John Richert, MD

Dr. John Richert describes the role of the office practice in this disease. Vague symptoms can be the first presentation of the relapsing-remitting form of this condition and lead to the appropriate tests and diagnosis. Here is where support for living with disability and frustations can be found.

Host: Maurice Pickard, MD

Guest: John Richert, MD

Dr. John Richert speaks about the genome abnormality in multiple sclerosis. The etiology is in early discovery stage and leading towards what he describes as the Three Cures.

Host: Maurice Pickard, MD

Guest: John Richert, MD

Dr. John Richert discusses 6 approved drugs that have changed the lives of the young patients who have this disabling disease. The early diagnosis of multiple sclerosis and the prompt institution of therapy is beginning to show dividends in that the disease does not progress as rapidly.

Host: Bruce Japsen

Guest: Jan Berger, MD

The annual cost of diabetes care in this country is rapidly approaching $200 billion, an astonishing figure that has nearly doubled since the beginning of this decade. Dr. Jan Berger, senior vice president and chief clinical officer of the Caremark Corporation, tells host Bruce Japsen that it does not have to be this way. Patients with this potentially deadly disease must work more efficiently in coordination with their physicians toward proper management of care.

Host: Bruce Japsen

Guest: Jan Berger, MD

It's problem enough in this country that there are millions without health insurance coverage, but even when they do have coverage, doctors don't know what their patients' co-pays are or what their ability is to pay. But Dr. Jan Berger, Chief Clinical Officer of pharmacy giant CVS/Caremark tells the Chicago Tribune's Bruce Japsen about the movement toward evidence-based health plan design that could give patients more information in choosing medical care.